GE HealthCare Technologies (NASDAQ:GEHC) Upgraded to Hold at BMO Capital Markets

GE HealthCare Technologies (NASDAQ:GEHC) was upgraded by BMO Capital Markets to a “hold” rating in a report released on Wednesday,Zacks.com reports.

GEHC has been the subject of a number of other reports. Piper Sandler lowered their price objective on GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Citigroup restated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Wednesday. Jefferies Financial Group reduced their target price on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Wells Fargo & Company lowered their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. Finally, BNP Paribas Exane dropped their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Ten investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $79.71.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $64.70 on Wednesday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The firm has a 50 day simple moving average of $63.33 and a 200 day simple moving average of $72.71. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The firm has a market cap of $29.43 billion, a P/E ratio of 15.48, a P/E/G ratio of 1.76 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Sell-side analysts predict that GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO James Saccaro acquired 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The stock was bought at an average cost of $60.60 per share, with a total value of $200,586.00. Following the completion of the transaction, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Watkin Phoebe L. Yang acquired 1,000 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 8th. The shares were purchased at an average cost of $63.01 per share, with a total value of $63,010.00. Following the completion of the transaction, the director directly owned 13,702 shares of the company’s stock, valued at $863,363.02. This trade represents a 7.87% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last quarter, insiders purchased 21,847 shares of company stock valued at $1,361,355. Corporate insiders own 0.36% of the company’s stock.

Institutional Trading of GE HealthCare Technologies

A number of institutional investors have recently made changes to their positions in the business. Laurel Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at $26,000. Optima Capital LLC acquired a new position in shares of GE HealthCare Technologies during the 4th quarter worth about $27,000. Godfrey Financial Associates Inc. acquired a new position in shares of GE HealthCare Technologies during the 4th quarter worth about $27,000. Montag A & Associates Inc. grew its holdings in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.